Journal for ImmunoTherapy of Cancer,
Journal Year:
2023,
Volume and Issue:
11(2), P. e006239 - e006239
Published: Feb. 1, 2023
Introduction
The
immunosuppressive
tumor
microenvironment
(TME)
is
a
major
barrier
to
the
efficacy
of
chimeric
antigen
receptor
T
cells
(CAR-T
cells)
in
glioblastoma
(GBM).
Transgenic
expression
IL15
one
attractive
strategy
modulate
TME.
However,
at
present,
it
unclear
if
could
be
used
directly
target
myeloid-derived
suppressor
(MDSCs),
cellular
component
GBM
Here,
we
explored
MDSC
express
IL15Rα
and
feasibility
exploiting
its
as
an
immunotherapeutic
target.
Methods
RNA-seq,
RT-qPCR,
flow
cytometry
were
determine
paired
peripheral
tumor-infiltrating
immune
patients
two
syngeneic
murine
models.
We
generated
expressing
IL13Rα2-CARs
secretory
(CAR.IL15s)
or
which
was
fused
CAR
serve
IL15Rα-targeting
moiety
(CAR.IL15f),
characterized
their
effector
function
vitro
IL13Rα2+glioma
Results
preferentially
expressed
myeloid,
B,
dendritic
patients’
GBMs.
In
vitro,
CAR.IL15s
CAR.IL15f
depleted
decreased
secretion
molecules
with
being
more
efficacious.
Similarly,
significantly
improved
survival
mice
TME
analysis
showed
that
treatment
resulted
higher
frequencies
CD8+T
cells,
NK,
B
but
decrease
CD11b+cells
tumors
compared
therapy
cells.
Conclusions
demonstrate
glioma
IL15Ra
these
can
targeted
incorporated
into
CAR.
Thus,
IL15-modified
act
dual
targeting
agent
against
GBM,
warranting
future
evaluation
early-phase
clinical
studies.
Cancer Discovery,
Journal Year:
2021,
Volume and Issue:
11(4), P. 933 - 959
Published: April 1, 2021
Abstract
Strategies
to
therapeutically
target
the
tumor
microenvironment
(TME)
have
emerged
as
a
promising
approach
for
cancer
treatment
in
recent
years
due
critical
roles
of
TME
regulating
progression
and
modulating
response
standard-of-care
therapies.
Here,
we
summarize
current
knowledge
regarding
most
advanced
TME-directed
therapies,
which
either
been
clinically
approved
or
are
currently
being
evaluated
trials,
including
immunotherapies,
antiangiogenic
drugs,
treatments
directed
against
cancer-associated
fibroblasts
extracellular
matrix.
We
also
discuss
some
challenges
associated
with
future
perspectives
this
evolving
field.
Significance:
This
review
provides
comprehensive
analysis
therapies
targeting
TME,
combining
discussion
underlying
basic
biology
clinical
evaluation
different
therapeutic
approaches,
highlighting
perspectives.
Physiological Reviews,
Journal Year:
2021,
Volume and Issue:
102(2), P. 1025 - 1151
Published: May 5, 2021
The
brain
harbors
a
unique
ability
to,
figuratively
speaking,
shift
its
gears.
During
wakefulness,
the
is
geared
fully
toward
processing
information
and
behaving,
while
homeostatic
functions
predominate
during
sleep.
blood-brain
barrier
establishes
stable
environment
that
optimal
for
neuronal
function,
yet
imposes
physiological
problem;
transcapillary
filtration
forms
extracellular
fluid
in
other
organs
reduced
to
minimum
brain.
Consequently,
depends
on
special
[the
cerebrospinal
(CSF)]
flushed
into
along
perivascular
spaces
created
by
astrocytic
vascular
endfeet.
We
describe
this
pathway,
coined
term
glymphatic
system,
based
dependency
endfeet
their
adluminal
expression
of
aquaporin-4
water
channels
facing
CSF-filled
spaces.
Glymphatic
clearance
potentially
harmful
metabolic
or
protein
waste
products,
such
as
amyloid-β,
primarily
active
sleep,
when
drivers,
cardiac
cycle,
respiration,
slow
vasomotion,
together
efficiently
propel
CSF
inflow
periarterial
brain's
space
contains
an
abundance
proteoglycans
hyaluronan,
which
provide
low-resistance
hydraulic
conduit
rapidly
can
expand
shrink
sleep-wake
cycle.
system
brain,
meets
requisites
maintain
homeostasis
similar
peripheral
organs,
considering
blood-brain-barrier
paths
formation
egress
CSF.
Cellular and Molecular Life Sciences,
Journal Year:
2021,
Volume and Issue:
78(6), P. 2429 - 2457
Published: Jan. 11, 2021
Abstract
Cerebrospinal
fluid
(CSF)
is
produced
by
the
choroid
plexuses
within
ventricles
of
brain
and
circulates
through
subarachnoid
space
skull
spinal
column
to
provide
buoyancy
maintain
homeostasis
cord.
The
question
how
CSF
drains
from
has
long
puzzled
scientists
clinicians.
For
many
decades,
it
was
believed
that
arachnoid
villi
or
granulations,
outcroppings
tissue
project
into
dural
venous
sinuses,
served
as
major
outflow
route.
However,
this
concept
been
increasingly
challenged
in
recent
years,
physiological
imaging
evidence
several
species
accumulated
showing
tracers
injected
can
instead
be
found
lymphatic
vessels
draining
cranium
spine.
With
high-profile
rediscovery
meningeal
located
dura
mater,
another
debate
emerged
regarding
exact
anatomical
pathway(s)
for
reach
system,
with
one
side
favoring
direct
efflux
advocating
pathways
along
exiting
cranial
nerves.
In
review,
a
summary
historical
contemporary
different
will
presented,
allowing
reader
gain
further
perspective
on
advances
field.
An
improved
understanding
fundamental
process
may
lead
novel
therapeutic
approaches
wide
range
neurological
conditions,
including
hydrocephalus,
neurodegeneration
multiple
sclerosis.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Sept. 10, 2020
Abstract
Traumatic
brain
injury
(TBI)
is
a
leading
global
cause
of
death
and
disability.
Here
we
demonstrate
in
an
experimental
mouse
model
TBI
that
mild
forms
trauma
severe
deficits
meningeal
lymphatic
drainage
begin
within
hours
last
out
to
at
least
one
month
post-injury.
To
investigate
mechanism
underlying
impaired
function
TBI,
examined
how
increased
intracranial
pressure
(ICP)
influences
the
lymphatics.
We
ICP
can
contribute
dysfunction.
Moreover,
show
pre-existing
dysfunction
before
leads
neuroinflammation
negative
cognitive
outcomes.
Finally,
report
rejuvenation
aged
mice
ameliorate
TBI-induced
gliosis.
These
findings
provide
insights
into
both
causes
consequences
suggest
therapeutics
targeting
system
may
offer
strategies
treat
TBI.
Angiogenesis,
Journal Year:
2023,
Volume and Issue:
26(3), P. 313 - 347
Published: April 15, 2023
In
multicellular
organisms,
angiogenesis,
the
formation
of
new
blood
vessels
from
pre-existing
ones,
is
an
essential
process
for
growth
and
development.
Different
mechanisms
such
as
vasculogenesis,
sprouting,
intussusceptive,
coalescent
well
vessel
co-option,
vasculogenic
mimicry
lymphangiogenesis,
underlie
vasculature.
many
pathological
conditions,
cancer,
atherosclerosis,
arthritis,
psoriasis,
endometriosis,
obesity
SARS-CoV-2(COVID-19),
developmental
angiogenic
processes
are
recapitulated,
but
often
done
so
without
normal
feedback
that
regulate
ordinary
spatial
temporal
patterns
formation.
Thus,
angiogenesis
presents
challenges
yet
opportunities
design
vascular-directed
therapies.
Here,
we
provide
overview
recent
insights
into
development
highlight
novel
therapeutic
strategies
promote
or
inhibit
to
stabilize,
reverse,
even
halt
disease
progression.
our
review,
will
also
explore
several
additional
aspects
(the
switch,
hypoxia,
angiocrine
signals,
endothelial
plasticity,
normalization,
cell
anergy)
operate
in
parallel
canonical
speculate
how
these
may
be
targeted
with
anti-angiogenic
Science Immunology,
Journal Year:
2021,
Volume and Issue:
6(63)
Published: Sept. 3, 2021
Early
engagement
of
the
lymphatic
system
by
solid
tumors
in
peripheral,
nonlymphoid
tissues
is
a
clinical
hallmark
cancer
and
often
forecasts
poor
prognosis.
The
significance
lymph
node
metastasis
for
distant
spread,
however,
has
been
questioned
large-scale
dissection
trials
likely
prevalence
direct
hematogenous
metastasis.
Still,
an
emerging
appreciation
immunological
role
tumor-draining
renewed
interest
its
basic
biology,
metastatic
progression,
antitumor
immunity,
patient
outcomes.
In
this
review,
we
discuss
our
current
understanding
early
mechanisms
through
which
engage
transport
condition
nodes,
these
changes
both
potential
implications
immunotherapy.